福瑞达: 鲁商福瑞达医药股份有限公司董事和高级管理人员所持本公司股份及其变动管理制度

Core Viewpoint - The document outlines the management system for the shares held by directors and senior management of Lushang Furuida Pharmaceutical Co., Ltd, emphasizing compliance with relevant laws and regulations regarding shareholding and trading activities [1][12]. Group 1: General Provisions - The system is established to strengthen the management of shares held by directors and senior management in accordance with various laws and regulations [1]. - The system applies to directors, senior management, and other specified individuals or organizations regarding their shareholding and trading activities [1]. Group 2: Information Reporting - The company secretary is responsible for managing the data of directors and senior management regarding their shareholdings and must report any violations to regulatory authorities [2]. - Directors and senior management must report their personal information and any changes within two trading days [5]. Group 3: Share Locking and Unlocking - Shares held by directors and senior management will be locked upon reporting their personal information, and specific conditions apply for transferring shares [10][11]. - Upon leaving the company, directors and senior management's shares will be locked for six months, after which they will be automatically unlocked [15]. Group 4: Share Trading and Disclosure - Directors and senior management must notify the company secretary of their trading plans and adhere to regulations regarding insider trading [16][17]. - There are specific periods during which directors and senior management are prohibited from trading shares, including before financial report announcements [23]. Group 5: Share Transfer Limitations - There are restrictions on the transfer of shares by directors and senior management, including limits on the percentage of shares that can be transferred annually [19][20]. - The document specifies conditions under which shares cannot be transferred, such as during investigations or legal proceedings [18]. Group 6: Compliance and Enforcement - Violations of the regulations may result in penalties from regulatory authorities, and the company may impose its own sanctions based on the severity of the violation [29]. - The document grants the board of directors the authority to interpret the provisions and mandates compliance with relevant laws and regulations [30][31].